ArticleRadiology. Artificial intelligence2025
Impact of Scanner Manufacturer, Endorectal Coil Use, and Clinical Variables on Deep Learning-assisted Prostate Cancer Classification Using Multiparametric MRI.
Article in Radiology. Artificial intelligence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Multimodal artificial intelligence in prostate cancer: integrating multiparametric MRI with clinicopathological, molecular, and functional imaging data.Abdominal radiology (New York) · 2026Review
- Review
- Summary from the 2025 International Society for Magnetic Resonance in Medicine workshop on body MRI: Unsolved problems and unmet needs.Magnetic resonance in medicine · 2026Review
- Medical machine learning operations: a framework to facilitate clinical AI development and deployment in radiology.European radiology · 2025Review
- Foundation models for radiology-the position of the AI for Health Imaging (AI4HI) network.Insights into imaging · 2025Review
- Artificial Intelligence Is Brittle: We Need to Do Better.Radiology. Artificial intelligence · 2025Article
- Reassessing deep learning (and meta-learning) computer vision as an efficient method to determine taphonomic agency in bone surface modifications.Biology methods & protocols · 2025Article
Corrections and comments
- Commented on by
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To assess the effect of scanner manufacturer and scanning protocol on the performance of deep learning models to classify aggressiveness of prostate cancer (PCa) at biparametric MRI (bpMRI). Materials and Methods In this retrospective study, 5478 cases from ProstateNet, a PCa bpMRI dataset with examinations from 13 centers, were used to develop five deep learning (DL) models to predict PCa aggressiveness with minimal lesion information and test how using data from different subgroups-scanner manufacturers and endorectal coil (ERC) use (Siemens, Philips, GE with and without ERC, and the full dataset)-affects model performance. Performance was assessed using the area under the receiver operating characteristic curve (AUC). The effect of clinical features (age, prostate-specific antigen level, Prostate Imaging Reporting and Data System score) on model performance was also evaluated. Results DL models were trained on 4328 bpMRI cases, and the best model achieved an AUC of 0.73 when trained and tested using data from all manufacturers. Held-out test set performance was higher when models trained with data from a manufacturer were tested on the same manufacturer (within- and between-manufacturer AUC differences of 0.05 on average,
Indexed as
Identifiers
39841063What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.